We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.25 | -7.46% | 15.50 | 15.00 | 16.00 | 16.75 | 15.50 | 16.75 | 595,508 | 10:34:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 644k | -2.04M | -0.0208 | -7.45 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/8/2017 05:46 | Calories in popular foods all over the press again. All playing into Optis hands for the future. S | shrewdmole | |
17/8/2017 21:33 | Well whoever it was selling gave us a '5 days only sale' of OPTI shares under 60p. I personally think it was retail investors panicking and selling as the chart broke through 60p support for the first time in almost 2 years. Let's face it, we were comforted by the 60p support. The buying volume and intraday reversal yesterday gave us an idea of interest in this stock - and by the sounds of it I was not the only one from this bb taking advantage! Just my opinion but I can see this steadily climbing up to 70/80p in anticipation of the next news - and then with a couple of deal announcements we'll hopefully break 85p once and for all and attract a whole new wave of investors - and new usernames! Just like Vanduke who is the latest with a great entry price (many LTHs inc. me have topped up in the 80s!) - welcome aboard! | parob | |
17/8/2017 20:59 | It may just be a coincidence, but I may have stumbled across the reason behind the latest and most significant retrace in the past 18 months, if not more. The last rally was halt at a peak of 81.28 (intraday) where it was evident profit taking was afoot. However on the 25th July this accelerated and coincided with a note to Hybridan clients that there were no longer covering 3 companies and clients should disregard all previous advise. "Coverage of the equity securities of the following companies has been discontinued. Investors should no longer rely upon our previously published reports, recommendations, price targets or estimates." OPTI was on that list. I am just speculating here, but I would wager a wealthy Hybridan client took this as a signal to offload. I view this as good news, as long as the seller(s) is close to closing his/her position. | elrico | |
17/8/2017 20:54 | Cheers guys and I would add:- possible acquisition in new application area (cognitive health)- other slimbiome agreements ("I cannot comment on specific deals but am excited at the level of interest in SlimBiome beyond GoFigure and Tata")- potential sale of GoFigure products outside of Europe | parob | |
17/8/2017 20:43 | Parob, A brief exchange with Elric today. He highlighted possible news building up over the next few weeks and months. Not sure why he has not posted the same here. I hope you dont mind Elric. I think technically, September is the month traditionally holidays draw to a close. However, SOH did say they have remained very busy over the summer months. If we look at the potential for RNS's; 8-9 nationals taking on LP-LDL At least on mid-range company in the regions of £3-5m pa Probable P&G as the US MN TATA product launches in India and Asia GoFigure retail listing by household name, thought to be Boots. SweetBiotix IPO SBTX share distribution SBTX commercial news | incanus | |
17/8/2017 20:05 | When each agreement is announced we will learn whether it's exclusive or non-exclusive and whether it's for: - a specific country (HLH is for Germany for example) - a territory (Pharmabiota covers Australia and New Zealand). - a region (which I take as a continent, Sacco and Nutrilinia are both for Europe) Here's a link to the interview where SOH talks about 20-30 distributors per region. Listen from 4.30 mins onwards: Should equate to regular newsflow over the coming weeks, months and years! | parob | |
17/8/2017 18:06 | It's all in some of yesterday's posts. The news that will be released in the coming weeks and months will enable you to judge the market capitilisation. An r.n.s could come at any time now. That's part of the reason for the extra buying. | bobdown2 | |
17/8/2017 18:00 | wouldnt it be lovely if we get an rns friday to underpin the beginning of the recovery. It just may continue into next week. | incanus | |
17/8/2017 14:30 | michaelmouse, its a shame the stl 1.5% annual divi is not closer to 30%, if it were you may have an investment case. Unfortunately for you it is not and will not prevent further double digit falls. Steve asks good questions, why pay a divi at all and at a mc9m why is it even listed. Bailout placing soon just to pay the divi, r&d and plc costs. bod are using divi payment to pull the wool. I am surprised you have not spotted this trick yet. Its been played before. | slartybartfaster | |
17/8/2017 12:47 | Dean Robert Hunt, do us all a favour and throw yourself off Southampton pier and take Lindsey with you just to help you with the rucksack full of bricks. There are lot smarter people here invested so we dont need to trash talk just to gain attention. If you want attention get a pup. | slartybartfaster | |
17/8/2017 12:42 | I was reading last night that Repatha (drug by Amgen, current share price of 117USD) cuts cholesterol by up to 71% WHEN combined with statins. Has there been any mention of the possible reduction of cholesterol if our LP-LDL was to be taken with statins in the same way? I guess this would potentially be investigated when more Pharma type trials take place maybe..? | loungeact | |
17/8/2017 12:40 | Very different company to Opti. Same arena but very very different approaches. Soh has got products out quickly as supplements rather than pharma tom prove the science and gain credibility. Any large retailer sticking go figure will be a bonus I'm sure as that was more a case of backing the science so it's a real added bonus if we do get say boots stocking it. S | shrewdmole | |
17/8/2017 12:33 | It's also over 50% down in the past year... | f3rdinand | |
17/8/2017 12:27 | Yeah but it has virtually doubled in the last couple of months though whl..... | bernieboy | |
17/8/2017 12:13 | 4D pharma are down 17% today - just thought I'd point that out! | whl2 | |
17/8/2017 11:38 | Bobdown2 - and the reverse is true - buyers provide good demand to sell into.... | essential | |
17/8/2017 11:23 | Any pull back and I'm in for more.Very good and well run AIM company. One to tuck away as it grows. | vanduke | |
17/8/2017 11:17 | For the non depressed among you, a bigger population just means a bigger market place for Opti products.. :-) | 1bokke | |
17/8/2017 11:08 | Mr Hunt, Some facts..1. This is a company that's been built by a highly qualified individual with a proven track record and has skin in the game.2. The company has a very strong and able bod.3. The science is proven and commercial traction is starting.4. Deals already signed have huge potential and this will encourage/force market place competitors to look at Opti's products.Try doing some research, I think you will be pleasantly surprised...:-) | 1bokke | |
17/8/2017 11:03 | I might get a job with the Samaritans, the population is too big already... | deanroberthunt | |
17/8/2017 11:01 | this is just a rise to the top of the descending channel, which it's at now.... | deanroberthunt |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions